These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 17296541

  • 1. Peripheral arterial disease: a review of disease awareness and management.
    Watson K, Watson BD, Pater KS.
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [Abstract] [Full Text] [Related]

  • 2. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Dec; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 3. Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention.
    Muir RL.
    J Vasc Nurs; 2009 Jun; 27(2):26-30. PubMed ID: 19486852
    [Abstract] [Full Text] [Related]

  • 4. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Wahlberg E.
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [Abstract] [Full Text] [Related]

  • 5. Office management of peripheral arterial disease.
    Aronow WS.
    Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM.
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [Abstract] [Full Text] [Related]

  • 7. [The best of vascular medicine in 2006].
    Mounier-Vehier C, Stephan D, Aboyans V, Beregi JP, Lacroix P, Léger P, Long A, Sevestre MA, Groupe vasculaire (SFC--Société française de médecine vasculaire).
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():47-55. PubMed ID: 17405565
    [Abstract] [Full Text] [Related]

  • 8. Management of peripheral arterial disease.
    Aronow WS.
    Cardiol Rev; 2005 Jan; 13(2):61-8. PubMed ID: 15705252
    [Abstract] [Full Text] [Related]

  • 9. Organising a nurse-driven PAD rehabilitation clinic within the vascular surgical department: what is required and are treatment goals reached--a prospective study?
    Sillesen H, Madelung S, Eldrup N, Roed M.
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):26-32. PubMed ID: 17070079
    [Abstract] [Full Text] [Related]

  • 10. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [Abstract] [Full Text] [Related]

  • 11. Atherosclerotic risk factor control in patients with peripheral arterial disease.
    Rehring TF, Sandhoff BG, Stolcpart RS, Merenich JA, Hollis HW.
    J Vasc Surg; 2005 May; 41(5):816-22. PubMed ID: 15886666
    [Abstract] [Full Text] [Related]

  • 12. Peripheral arterial disease in women.
    Aronow WS.
    Maturitas; 2009 Dec 20; 64(4):204-11. PubMed ID: 19853389
    [Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN, Modrall JG.
    Semin Vasc Surg; 2007 Mar 20; 20(1):10-4. PubMed ID: 17386359
    [Abstract] [Full Text] [Related]

  • 14. How optimal is the medical management of patients prior to major reconstructive vascular surgery? The results of a cross-sectional study.
    Marshall C, Lin PH, Huynh TT, Kougias P.
    Vasc Endovascular Surg; 2009 Mar 20; 43(3):238-43. PubMed ID: 19190039
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
    Blinc A, Poredos P.
    Eur J Clin Invest; 2007 Mar 20; 37(3):157-64. PubMed ID: 17359482
    [Abstract] [Full Text] [Related]

  • 16. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O, Welten GM, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2008 Jan 20; 35(1):59-60. PubMed ID: 17719805
    [No Abstract] [Full Text] [Related]

  • 17. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW, Jaff MR.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):475-89. PubMed ID: 18307227
    [Abstract] [Full Text] [Related]

  • 18. [Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)].
    Béraut E, Cambou JP, Guilhem JM, Vaysse N, Labro S, Séverac D, Boccalon H, Bura-Rivière A.
    J Mal Vasc; 2008 Feb 01; 33(1):1-11. PubMed ID: 18187280
    [Abstract] [Full Text] [Related]

  • 19. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
    Cavendish JJ, Safani M.
    Curr Med Res Opin; 2004 Nov 01; 20(11):1851-5. PubMed ID: 15537486
    [Abstract] [Full Text] [Related]

  • 20. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
    Ferreira AC, Macedo FY.
    Ann Med; 2010 Mar 01; 42(2):139-50. PubMed ID: 20156042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.